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Abstract
Background: Pathology of white matter in brains of patients with major depressive disorder (MDD) is well-documented, but 
the cellular and molecular basis of this pathology are poorly understood.
Methods: Levels of DNA oxidation and gene expression of DNA damage repair enzymes were measured in Brodmann area 
10 (BA10) and/or amygdala (uncinate fasciculus) white matter tissue from brains of MDD (n=10) and psychiatrically normal 
control donors (n=13). DNA oxidation was also measured in BA10 white matter of schizophrenia donors (n=10) and in 
prefrontal cortical white matter from control rats (n=8) and rats with repeated stress-induced anhedonia (n=8).
Results: DNA oxidation in BA10 white matter was robustly elevated in MDD as compared to control donors, with a smaller 
elevation occurring in schizophrenia donors. DNA oxidation levels in psychiatrically affected donors that died by suicide 
did not significantly differ from DNA oxidation levels in psychiatrically affected donors dying by other causes (non-suicide). 
Gene expression levels of two base excision repair enzymes, PARP1 and OGG1, were robustly elevated in oligodendrocytes 
laser captured from BA10 and amygdala white matter of MDD donors, with smaller but significant elevations of these gene 
expressions in astrocytes. In rats, repeated stress-induced anhedonia, as measured by a reduction in sucrose preference, was 
associated with increased DNA oxidation in white, but not gray, matter.
Conclusions: Cellular residents of brain white matter demonstrate markers of oxidative damage in MDD. Medications that 
interfere with oxidative damage or pathways activated by oxidative damage have potential to improve treatment for MDD.
Keywords: oxidative stress, DNA, messenger RNA, anhedonia, oligodendrocyte
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Introduction
Brain white matter pathology is a feature of several psychiatric 
diseases, including major depressive disorder (MDD) and bipolar 
disorder. In living patients, white matter pathology has been inti-
mated by in vivo imaging studies, including diffusion tensor imag-
ing (DTI) to ascertain anisotropy and diffusivity in white matter 
and T2- or proton density weighted images from MRI to meas-
ure white matter hyper-intensities or white matter volumes. 
Abnormalities in DTI, including reduced anisotropy, and elevated 
numbers of white matter hyper-intensities have been reported in 
MDD patients (Taylor et al., 2007; Tham et al., 2011). The cellular 
basis of white matter abnormalities has not been conclusively 
identified, but is thought to be a result of pathology of myelinat-
ing cells (oligodendrocytes), vascular tissues (especially in the 
elderly), astrocytes, and/or microglia that reside in white matter 
regions of the brain. In MDD, cellular abnormalities have been 
reported in white matter obtained postmortem from depressed 
patients who died by suicide as compared to individuals dying 
from other medical causes and lacking a psychiatric diagnosis. 
These abnormalities include alterations in astrocyte morphol-
ogy (Torres-Platas et al., 2011), reduced myelin staining (Regenold 
et al., 2007), and aberrations in oligodendrocyte gene expressions 
and morphology (Szebeni et al., 2014; Rajkowska et al., 2015).
Recently, we discovered shortened telomeres in white mat-
ter oligodendrocytes collected from postmortem brains of MDD 
donors, as compared to age-matched psychiatrically normal 
control donors (Szebeni et al., 2014). Mechanisms contributing 
to telomere shortening in other cell types include cell divisions 
and telomere DNA damage mediated by oxidation events (Von 
Zglinicki, 2002). Since oligodendrocytes are post-mitotic, we 
speculated that telomere shortening in oligodendrocytes from 
MDD subjects may be secondary to oxidative damage of tel-
omere DNA. Evidence of oxidative damage in MDD includes a 
wealth of support such as elevated biological products of oxida-
tive stress (Forlenza and Miller, 2006; Bilici et  al., 2001; Selley, 
2004; Sarandol et al., 2006, 2007; Dimopoulos et al., 2008; Yager 
et al., 2010) and reduced plasma concentrations of free radical 
scavengers (Peet et al., 1998; Maes et al., 2000; Owen et al., 2005).
The primary targets of reactive oxygen on DNA are oxidation-
sensitive guanine nucleotides due to their low ionization poten-
tial in comparison to other nucleic acid bases (Kawanishi et al., 
2001). Guanine-rich areas of DNA, such as telomere DNA and 
promoter/enhancer areas of genes, are thereby particularly sen-
sitive to oxidative attack. One of the fastest cellular responses 
to oxidative damage of DNA is poly(ADP-ribosyl)ation, a post-
translational modification of nuclear proteins, catalyzed by the 
nuclear enzyme poly(ADP)-ribose polymerase-1 (PARP1) (Gibson 
and Kraus, 2012). In the CNS, PARP1 is ubiquitously distributed 
in glia and neurons, found predominantly in the nucleus, and 
exerts a vast array of nuclear effects that influence the process 
of DNA repair. When DNA is oxidized, 8-oxoG DNA glycosylase 
(encoded by OGG1) excises oxidized nucleotides (Hazra et  al., 
2001). Gene expression of PARP1 and OGG1 is upregulated by oxi-
dative stress (Liu et al., 2000; Lan et al., 2003; Adaikalakoteswari 
et  al., 2007). Hence, PARP1 and OGG1 are two key mediators 
of the cellular apparatus for base excision and repair (BER) in 
response to oxidative attack of DNA.
Our previous work (Szebeni et  al., 2014) demonstrating tel-
omere shortening in white matter oligodendrocytes from MDD 
brain donors strongly implicates elevated levels of DNA oxida-
tion of white matter in MDD. In the present study, we wished to 
confirm this by directly measuring a common product of DNA 
oxidation, 8-hydroxy-deoxyguanosine (8OHdG), in white matter 
from MDD donors. Since nearly all MDD donors studied previ-
ously (Szebeni et al., 2014) died by suicide, it seemed important to 
determine whether biological factors specific to suicidal behav-
ior, rather than depression, might contribute to vulnerabilities 
to DNA oxidation. To evaluate this, MDD donors that died as a 
result of suicide or natural medical deaths were included in the 
present study. To increase the sample size of the non-suicide vs 
suicide comparison, we also evaluated DNA oxidation in a group 
of schizophrenia brain donors that died as a result of suicide or 
natural medical deaths. Given the roles of PARP1 and OGG1 in 
DNA damage repair, levels of expression of PARP1 and OGG1 were 
evaluated in specific white matter cell populations collected by 
laser capture microdissection from MDD and psychiatrically nor-
mal control brain donors. In addition, white matter DNA oxida-
tion was studied in rats that demonstrated anhedonia following 
repeated exposure to both social defeat stress and chronic unpre-
dictable stress, to examine DNA oxidation associated with anhe-
donia in the absence of the many variables that can complicate 
human postmortem brain tissue studies. The results of this study 
provide further evidence for oxidative damage of white matter 
oligodendrocytes in MDD, implicating oligodendrocyte pathology 
as a contributory factor in the psychopathology of MDD.
Methods
Human Subjects and Tissue Acquisition
The methods for obtaining tissues from psychiatrically charac-
terized brain donors is exactly as described previously (Chandley 
et  al., 2013). Briefly, tissues are obtained at autopsy at the 
Medical Examiner’s Office of Cuyahoga County, OH (USA) using 
an approved Institutional Review Board protocol. Axis I diagno-
ses according to the Diagnostic and Statistical Manual of Mental 
Disorders (4th ed.) (DSM-IV) (American Psychiatric Association, 
1994) were established following structured interviews of next-of-
kin of all subjects using the Structured Clinical Interview for DSM 
Axis I Disorders modified for third-person reporting (First et al., 
1996). Table 1 shows demographic information of brain donors. 
Significance Statement
Currently available antidepressants produce remission in only two-thirds of patients with depression, a disorder that affects over 
10 million people in the US each year. The proposed study deviates from traditional studies of the pathobiology of depression 
that focus on systems directly affected by current and less than adequate antidepressants. This study unearths vulnerabilities of 
oligodendrocytes in brain white matter in major depressive disorder. Oligodendrocytes are critical for the transmission of infor-
mation from one region of the brain to another. The findings provide a theoretical cellular and molecular basis for brain white 
matter pathology observed in living patients with depression by in vivo brain imaging. Further study of the affected pathways 
in oligodendrocytes has the potential to uncover novel targets for drugs that could prevent or reverse white matter pathology in 
depression, and ultimately improve overall treatment of this disorder.
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Table 1. Subject Demographics
Subject Code Gender pH RINa PMIb Smoker Toxicology Axis I Diagnosis Suicide Tissue Assay 
Normal control donors
1 c M 6.47 7.3 17.0 No NDDc None No UFe, BA10 Oxf, GEg
2 c M 6.49 6.9 23.0 No,hxd Norpropoxyphene, 
propoxyphene, oxycodone
None No UF, BA10 Ox, GE
3 c M 6.28 6.4 17.0 No None None No UF GE
4 c M 6.42 7.4 11.0 No NDD None No UF, BA10 Ox, GE
5 c M 6.10 7.1 25.0 No Propoxyphene None No UF, BA10 Ox, GE
6 c M 6.95 6.8 19.0 No NDD None No UF, BA10 Ox, GE
8 c M 6.76 7.0 11.0 No NDD None No UF GE
9 c M 6.72 6.7 16.0 No None None No UF GE
10 c M 6.88 8.4 17.0 Yes NDD None No UF, BA10 Ox, GE
11 c M 6.79 7.6 6.0 No,hx Lidocaine None No UF, BA10 Ox, GE
12 c M 6.95 7.2 24.0 Yes None None No UF GE
13 c M 6.80 7.1 17.0 Yes None None No UF GE
14 c M 6.98 7.4 9.0 Yes NDD None No BA10 Ox, GE
15 c M 6.78 7.7 21.0 Yes Ethanol None No BA10 GE
16 c F 6.57 N/Ah 32.5 No NDD None No BA10 Ox
18 c M 6.58 N/A 22.0 No NDD None No BA10 Ox
19 c F 6.59 N/A 21.0 Yes Brompheniramine None No BA10 Ox
20 c M 6.71 N/A 24.0 No Ethanol None No BA10 Ox
MEAN 6.66 7.21 18.5
SEM 0.06 0.13 1.5
Donors with Major Depressive Disorder
1 d M 6.67 6.9 31.0 No Ethanol MDD Yes UF, BA10 Ox, GE
2 d M 6.80 6.8 20.0 Yes Acetone MDD Yes UF, BA10 Ox, GE
3 d M 6.48 5.8 18.0 No CO 83% MDD Yes UF GE
4 d M 6.27 7.5 30.0 Yes CO 75% MDD Yes UF, BA10 Ox, GE
5 d M 6.84 7.0 11.0 No EtOH MDD Yes UF, BA10 Ox, GE
6 d M 6.26 7.5 17.0 No NDD MDD No UF, BA10 Ox, GE
8 d M 6.70 6.7 20.0 No Diphenhydramine MDD Yes UF GE
9 d M 6.23 7.0 21.0 Hx NDD MDD Yes UF GE
10 d M 6.91 8.0 18.0 Yes NDD MDD Yes UF, BA10 Ox, GE
11 d M 6.32 6.8 20.0 No Ethanol MDD Yes UF, BA10 Ox, GE
12 d M 6.20 6.7 30.0 Yes Codeine MDD Yes UF GE
13 d M 6.60 6.6 17.0 No NDD MDD Yes UF GE
14 d M 6.24 6.7 19.2 Yes Chlorpheniramine MDD No BA10 Ox, GE
15 d M 6.80 7.2 26.0 Yes Ethanol MDD Yes BA10 GE
26 d M 6.50 N/A 14.0 No Tolnaftate, brucine MDD No BA10 Ox
27 d M 6.67 N/A 26.0 Yes Sertraline, carbamazepine MDD No BA10 Ox
MEAN 6.53 6.9 21.1
SEM 0.06 0.1 1.5
Donors with Schizophrenia
16 d F 5.74 N/A 18.0 No NDD SCZi No BA10 Ox
17 d M 6.62 N/A 16.0 Yes NDD SCZ No BA10 Ox
18 d M 6.77 N/A 16.0 Yes NDD SCZ No BA10 Ox
19 d F 6.58 N/A 6.0 Yes Amoxapine, loxapine SCZ No BA10 Ox
20 d M 6.78 N/A 10.0 Yes Ethanol SCZ Yes BA10 Ox
21 d M 6.76 N/A 24.0 Yes NDD SCZ Yes BA10 Ox
22 d M 6.71 N/A 19.0 No NDD SCZ Yes BA10 Ox
23 d M 6.70 N/A 15.0 Yes Ethanol, cocaine, 
diphenydramine
SCZ Yes BA10 Ox
24 d M 6.70 N/A 24.0 No Olanzapine SCZ Yes BA10 Ox
25 d M 6.55 N/A 12.2 Yes Olanzapine SCZ Yes BA10 Ox
MEAN 6.59 N/A 16.7
SEM 0.08 N/A 1.7
a RNA integrity number generated by the Agilent Bioanalyzer 2100.
b Postmortem interval.
c No drugs detectable.
d History.
e Uncinate fasciculus.
f DNA oxidation assay.
g Gene expression assay.
h Not applicable to donors that were used for only DNA oxidation studies.
i Schizophrenia.
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All diagnoses were active at the time of death. Psychiatrically 
normal control, MDD and schizophrenia donors were matched 
as closely as possible for age, gender, postmortem interval (PMI), 
tissue pH and smoking history. Two control donors had current 
alcohol abuse at the time of death while four MDD subjects 
had comorbid alcohol abuse disorder and one MDD subject had 
comorbid alcohol dependence. In addition, two donors that had 
schizophrenia had active alcohol abuse. Control donors died as a 
result of cardiovascular disease (11), pulmonary emboli (2), homi-
cide (2), aneurysm (1), crushing impact (1), and pancreatitis (1). 
MDD donors died as a result of suicide (14), cardiovascular disease 
(3), and gunshot wound (1). Donors that had schizophrenia died 
as a result of cardiovascular disease (2), pulmonary disease (1), 
homicide (1) and suicide (6). The range of ages was 17 to 82 y for 
control donors (47.9 ± 4.1 y), 16 to 86 y for MDD donors (50.5 ± 5.0 
y), and 16 to 78 y for schizophrenia donors (39.7 ± 5.1 y). All demo-
graphic details for each donor are not included in Table 1 to pro-
tect the identity of donors. Two frozen brain areas from the right 
hemisphere were obtained for study, BA10 including its white 
matter and the amygdala containing the uncinate fasciculus.
Measurement of 8OHdG
Frozen human right BA10 tissue was cut on a cryostat microtome 
to 50 µm thick sections and then white matter was punch-dis-
sected using a 3.5 mm trephine dissection tool at -20oC. White 
matter from rat prefrontal cortex was similarly punch-dis-
sected with a 1.5 mm trephine at the level of Plate 9 (Paxinos 
and Watson, 1986). Genomic DNA was isolated from 10 punches 
from each species using the QiaAmp DNA microkit (Qiagen, 
Valencia, CA). Levels of 8OHdG were measured from the DNA 
isolated from white matter tissue using a commercially avail-
able ELISA (JaICA, Shizuoka, Japan).
Immunohistochemistry for Laser Capture 
Microdissection
Frozen tissue sections (10 μm) cut on cryostat microtome at -20oC 
were prepared for laser capture microdissection as previously 
described (Ordway et  al., 2009), including rapid immunohisto-
chemical staining for 2’,3’-cyclic nucleotide 3’ phosphodiester-
ase (CNPase; Abcam, Cambridge, MA) at 37ºC and glial fibrillary 
acidic protein GFAP (GFAP; Thermo Fisher Scientific, Waltham, 
MA) at 22ºC. Following immunostaining, 500 oligodendrocytes 
or 500 astrocytes were captured onto CapSure Macro caps 
within 2 h for each sample using a ArcturusXT (Thermo Fisher 
Scientific, Waltham, MA) and incubated at 42ºC for 30  min in 
RNA lysis buffer immediately following capture.
RNA Purification and End-Point PCR
Total RNA extraction, cDNA synthesis and endpoint PCR was 
performed as previously described (Szebeni et al. 2014). Genes 
used in endpoint PCR included three reference genes (glycer-
aldehyde-3-phosphate dehydrogenase, GAPDH; 18S ribosomal 
1 RNA, RNA18S1; ubiquitin C, UBC), identification genes for 
each cell type (CNP; GFAP) and target genes (PARP1, OGG1), see 
Supplementary Table S1 for more information including primer 
sequences and NCBI accession numbers. All experiments 
were performed in triplicate using an Agilent 2200 Tapestation 
Instrument (Agilent Technologies, Santa Clara, CA).
Laboratory Animals
The use of animals was approved by the University Committee 
on Animal Care. Male Sprague-Dawley rats (Envigo, Inc., 
Indianapolis, IN, USA) weighing 225–250 g upon arrival served as 
‘intruders’ in the social defeat paradigm. Animals were individu-
ally housed and were provided enrichment per the NIH Guideline 
for the Care and Use of Animals. Rats were housed on a 12  h 
on/12 on off light/dark cycle in a climate-controlled vivarium.
Female Rat Fallopian Tube Ligature
Fourteen female Sprague-Dawley rats (Envigo, Inc., Indianapolis, 
IN) weighing 175–199 g upon arrival were allowed 6 days of habit-
uation to animal colony conditions. Rats then underwent surgery 
to ligate the fallopian tubes (Aygen et al., 2002), and then were 
allowed 7 days to recover before being mated with a male rat.
Social Defeat Stress (SDS)
Sixteen male Long-Evans hooded rats (‘resident’) were each 
mated with a female Sprague-Dawley (ligated) rat for a 7-day 
period. On the eighth day, the female was removed, and an 
‘intruder’ rat was placed into the cage for a 5 min period. In all 
cases, the resident established dominance over the intruder. The 
interaction was stopped when a rat demonstrated a supine pos-
ture for up to 10 s, had received up to 10 attack bites, or 5 min 
had elapsed. SDS was performed daily for 10 consecutive days, 
and was performed between 0900 and 1000  h. Controls were 
handled by the experimenter each day during this same time 
period, but were not exposed to SDS.
Chronic Unpredictable Stress (CUS)
CUS was performed after SDS on the same day, but at random 
times either during the day or evening. Unpredictable stressors 
included a 10-min cold (18ºC) or a 15-min warm swim (24ºC) that 
was conducted in a tank 61 cm in diameter, a tilted cage for 24 h, 
restraint stress for 30  min, or 1  h of shaking/crowding. These 
different stressors were randomly arranged, given during either 
the light or dark cycle and given each day for 10 consecutive 
days. All rats were exposed to each of these 5 stressors twice 
during the 10-day period. Controls were handled by the experi-
menter each day during the same time period but not exposed 
to the stressor.
Sucrose Preference
Sucrose preference was performed the final three days of stress 
induction (days 8–10), using a procedure based on that of D’Aquila 
et al (1997). Animals were given two bottles on their cages between 
the 1900 and 2100 h on each day that it was performed (the first 
2 h of the dark cycle) with one bottle containing tap water and 
the other containing 0.8% sucrose. Amounts of sucrose consumed 
were calculated as percentages of the total amount of fluid con-
sumed during the 2 h period on each of the 3 days of testing.
Social Interaction Test
The social interaction test was given 24  h after the last social 
defeat stress on day 11 of behavioral testing. The interaction test 
was conducted exactly as previously described (Brown et al., 2011).
Statistical Analysis
A Grubb’s test was used to remove statistical outliers from each 
dataset prior to analyses. Statistical analyses were performed 
as indicated using IBM SPSS Statistics (version 23.0) and data 
were graphed using GraphPad Prism (version 5.0b, GraphPad 
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Software, La Jolla, CA). For analysis of variance, a Bonferroni-
correction was applied to limit Type I error in multiple post-hoc 
comparisons. All data are expressed as mean ± standard error 
of the mean.
Results
DNA Oxidation in Human BA10 White Matter
Levels of 8OHdG in BA10 white matter were significantly 
impacted by the psychiatric status of brain donors (F=20.9[2,30], 
p=2.1e-6). Using age as a covariate did not alter the outcome 
of the analysis. Post hoc comparisons revealed robustly ele-
vated levels of 8OHdG in MDD donors compared to psychiat-
rically normal control donors, but also significantly elevated 
8OHdG levels in schizophrenia donors (Figure 1A). Since 
many of the MDD donors and schizophrenia donors died as a 
result of suicide, the possibility that oxidation of white mat-
ter DNA might be related to suicide rather than psychiatric 
disease was evaluated by grouping the two psychiatric ill-
nesses together and comparing those that died as a result 
of suicide to those who had non-suicide deaths. This com-
parison was made with the caveat that schizophrenia donors, 
particularly those that may have suicided during an acute 
psychosis, are behaviorly very different from MDD donors of 
whom none had a history of psychosis. Levels of 8OHdG in 
white matter in suicide brain donors were not significantly 
different from 8OHdG levels in non-suicide brain donors, but 
8OHdG levels were significantly elevated in both suicide and 
non-suicide psychiatric groups compared to the normal con-
trol group (Figure 1B). Suicide vs non-suicide was also evalu-
ated within each psychiatric diagnosis, albeit the sample 
sizes for these comparisons were much smaller. Comparison 
of 8OHdG levels in MDD donors dying as a result of suicide 
(n=6, 1.96 ± 0.12 ng/ml) to those MDD donors that died of 
natural/medical causes (n=4, 2.10 ± 0.21 ng/ml) were not sig-
nificantly different (t[8]=0.61; p=0.56). Likewise, 8OHdG levels 
in schizophrenia donors dying as a result of suicide (n=6, 1.70 
± 0.11 ng/ml) was not significantly different from schizophre-
nia donors that died of natural/medical causes (n=4, 1.71 ± 
0.08 ng/ml; t[8]=0.12; p=0.91).
PARP1 and OGG1 Gene Expression in Human 
BA10 Glia
Expression levels of PARP1 and OGG1 were measured in oligoden-
drocytes and astrocytes collected by laser capture microdissec-
tion of BA10 white matter from MDD donors and normal control 
donors. Glia were also laser captured from a second white mat-
ter region (uncinate fasciculus) that was too small for measure-
ment of DNA oxidation. We had previously observed indirect 
evidence of DNA damage in uncinate fasciculus (Szebeni et al., 
2014). Multivariate ANOVA revealed a significant group effect 
on PARP1 expression in the two white matter regions (F=41.0[4,9]; 
p<1x10-5). Using age, RNA integrity (RIN), pH, and PMI as covari-
ates in the analysis did not alter the outcome of the analysis. 
Post-hoc Bonferroni adjusted comparisons of MDD to control 
donors showed statistically higher expressions of PARP1 in oligo-
dendrocytes in uncinate fasciculus and BA10, and in astrocytes 
only in BA10 white matter (Figure 2A and 2B). Similarly, a signifi-
cant group effect (control vs MDD) was observed for the expres-
sion of OGG1 (F=22.6[4,10]; p<1x10
-4). As for PARP1 expression, using 
covariates in the analysis did not alter the outcome of the analy-
sis. Post-hoc comparisons demonstrated significantly elevated 
OGG1 expression in oligodendrocytes in both uncinate fasciculus 
and BA10 white matter (Figure 2C). However, no significant dif-
ference in levels of OGG1 expression was observed in astrocytes 
from the two white matter regions (Figure 2D). In the samples 
collected for laser capture microdissection, there were not a suf-
ficient number of MDD donors who had not died as a result of 
suicide to statistically evaluate the potential contribution of sui-
cide to gene expression changes. However, for oligodendrocytes 
collected from uncinate fasciculus, where there were two non-
suicide donors, PARP1 and OGG1 gene expression levels in both 
non-suicide MDD donors were higher than the levels of PARP1 
and OGG1 gene expression levels of every control donor.
The potential that PARP1 and OGG1 expression levels were 
linked to DNA oxidation levels was examined. As noted in 
Methods, DNA oxidation levels were determined in a subset of 
brain donors for which gene expressions were measured, i.e. 
6–8 donors per group. In these small samples, there were no 
significant correlations between DNA oxidation levels in BA10 
white matter and gene expression levels of either BER enzyme 
in oligodendrocytes or astrocytes from BA10 white matter 
Figure 1. Measurement of 8-hydroxydeoxyguanosine (8OHdG) immunoreactivity in homogenates of BA10 white matter from psychiatrically normal control donors 
(CON, n=13), major depressive disorder donors (MDD; n=10) and schizophrenia donors (SCHZ; n=10). The two psychiatric groups include suicide and non-suicide causes 
of death in panel A. The same data appears in panel B with psychiatric groups divided according to cause of death, i.e. suicide (n=12 consisting of 6 MDD and 6 SCHZ 
donors) and non-suicide (n=8 consisting of 4 MDD and 4 SCHZ donors). P values for group comparisons that reached statistical significance are noted.
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when considering data from both study groups (Supplementary 
Table S2).
Potential correlations between PARP1 and OGG1 expression 
levels were also evaluated. Here, Pearson correlations were com-
puted after grouping together data from the two brain regions, 
examining oligodendrocytes and astrocytes separately. Data 
from control and MDD donors were also examined separately 
because levels of both mRNAs were significantly different 
comparing the two donor groups. Levels of PARP1 expression 
significantly correlated with OGG1 expression levels in both 
oligodendrocytes and astrocytes, and in both control and MDD 
donors (Figure 3).
Evaluation of Potential Modifiers of DNA Oxidation 
and DNA Repair Enzyme Gene Expression in Human 
Postmortem Brain Samples
The potential impact of several demographic and biological 
variables on DNA oxidation and gene expression was evalu-
ated. Levels of DNA oxidation modestly correlated with age in 
the control group (r=-0.56, p=0.048). However, DNA oxidations 
levels did not significantly correlate with age in the psychiatric 
groups, whether considered separately (MDD, r=-0.28, p=0.33; 
schizophrenia, r=0.34, p=0.33) or when MDD and schizophrenia 
donors were grouped together (r=-0.34, p=0.14). To examine a 
potential effect of smoking on DNA oxidation, known smokers 
and non-smokers were compared regardless of psychiatric sta-
tus. DNA oxidation levels were not significantly different com-
paring smokers to non-smokers (t=0.42[27], p=0.967). Likewise, 
the potential effect of chronic alcohol exposure was examined 
by grouping all alcohol abuse/dependence donors regardless of 
psychiatric status (n=9) and comparing to those without alcohol 
abuse/dependence (n=24). As such, alcohol exposure had no sig-
nificant effect on white matter DNA oxidation levels (t=-0.748[31], 
p =0.46).
Factors such as age, tissue pH, PMI, and RIN were consid-
ered as possible modifiers of gene expression data. None of 
these factors were significantly correlated with OGG1 or PARP1 
expression levels in oligodendrocytes collected from either the 
uncinate fasiculus or BA10 white matter (Supplementary Tables 
S3 and S4). The effect of cigarette smoking on PARP1 and OGG1 
expression was evaluated by comparing smokers to nonsmok-
ers regardless of psychiatric status. There was no significant 
effect of smoking on levels of PARP1 and OGG1 gene expression 
(PARP1: F=1.35[8,20]=0.35; OGG1: F1[8,20]=1.142, P=0.38). Comparisons 
of age, RIN, PMI, and RIN were made for all group comparisons. 
There were no significant differences in group comparisons 
for any of these variables for DNA oxidation measurements 
(Supplementary Table S5). Likewise, there were no significant 
differences between groups for these variables for the gene 
expression measurements, with the exception of a modest dif-
ference in mean PMI values (p=0.04; Supplementary Table S6). 
There were only four female donors available for study, two 
control donors and two age-matched schizophrenia donors. 
Tissues from these subjects were used to measure DNA oxida-
tion in BA10 white matter (see Table 1). As observed comparing 
all schizophrenia donors to control donors, DNA oxidation levels 
were higher in female schizophrenia donors (1.74 and 1.90 fg/
ml; average 1.82 fg/ml) as compared to female control donors 
(1.00 and 1.29 fg/ml; average 1.14 fg/ml), although the sample 
size is too small to permit a statistical comparison.
Finally, the potential relationship between length of ill-
ness and DNA oxidation and DNA repair enzyme gene expres-
sion was evaluated. No significant correlation between length 
Figure 2. Expression levels of BER enzyme genes, PARP1 (panels A and B) and OGG1 (panels C and D) in laser captured oligodendrocytes (panels A and C) and astrocytes 
(panels B and D) from BA10 white matter of psychiatrically normal control donors (white bars) and MDD donors (black bars). P values for group comparisons that 
reached statistical significance are noted.
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of illness and levels of DNA oxidation were observed for MDD 
brain donors (Supplementary Table S7). Likewise, there were no 
significant correlations between length of illness and expression 
levels of PARP1 or OGG1 (Supplementary Table S7).
Psychological Stress-Induced Depressive Behavior 
in Rats
Rats were exposed daily to two classical psychological stress-
ors, social defeat and unpredictable stress, for 10  days. The 
rational for a double stress paradigm was to reduce poten-
tial for habituation to stressors. Anhedonia was quantified 
in stressed and non-stressed control rats using the 2-bottle 
sucrose preference task over the last three days of the stress 
paradigm (days 8–10). Social interaction was assessed the day 
after the last stressor (day 11). A  repeated measures ANOVA 
revealed that rats exposed to stress demonstrated a significant 
reduction in preference for sweetened water across the three 
test days (Figure  4A; F=28.9[1,26], P=1.3 x 10
–5). Likewise, time 
spent in the interaction zone was also significantly reduced in 
stressed rats (Figure  4B; t=2.59[26], P=0.016). DNA oxidation in 
white matter from the prefrontal cortex from these rats, meas-
ured two days following the last stressor, was significantly 
elevated in stressed rats as compared to unstressed controls 
(Figure 4C; t=3.7[14], P=0.002). In contrast, no significant change 
in levels of DNA oxidation was observed in prefrontal corti-
cal gray matter comparing stressed to control rats (Figure 4C; 
t=0.045[14]; P=0.96).
Figure 4. The effect of repeated exposure to social defeat stress plus unpredictable stress on sucrose preference in the two-bottle choice task (A), time spent in the 
interaction zone (B), and DNA oxidation levels (C) measured in prefrontal cortical white and gray matter of rats. For each graph, white bars indicate handled control 
rats and black bars indicate stressed rats. Sucrose preference was measured over the last three days (day 8–10) of the stress paradigm (N=14 rats per group). Repeated 
measures ANOVA revealed a significant effect of stress on sucrose preference across the three days (p = 1x10-5). Interaction zone times were measured on the 11th day, 
24 h after the last social defeat session (N=14 rats per group). DNA oxidation levels were measured two days after the last stressor (day 12) in 8 rats from each of the 
same two groups of rats used for the two-bottle choice task and interaction zone measurements. Statistically significant comparisons are shown above the bars for 
panels B and C.
Figure 3. Relationship between expression levels of PARP1 and OGG1 in white matter glia in normal control (panels A and C) and MDD (panels B and D) donors. Each 
graph shows gene expression levels in cells laser captured from both uncinated fasciculus and BA10 white matter for each group of subjects. Pearson correlations and 
p values are shown.
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Discussion
The present study demonstrates elevated levels of DNA oxida-
tion in prefrontal cortical (BA10) white matter from brain donors 
with an active MDD at the time of death, as compared to psy-
chiatrically normal control donors. The elevated DNA oxidation 
in MDD was accompanied by increased levels of expression of 
the DNA damage sensor gene PARP1 and the DNA repair gene 
OGG1 in white matter oligodendrocytes. Moreover, elevated 
DNA oxidation was observed in prefrontal cortical white mat-
ter from rats demonstrating anhedonia after repeated exposure 
to psychological stress. These novel findings provide evidence 
that oxidative damage to white matter may contribute mecha-
nistically to white matter pathologies that have been described 
(Tham et  al., 2011) in imaging studies of living MDD patients. 
Furthermore, DNA oxidation in white matter in MDD may be 
linked to psychological stress-induced oxidative stress that 
yields damage to vulnerable cell populations in the brain.
The brain is susceptible to damaging effects of ROS, primar-
ily due to a very high rate of metabolism and oxygen consump-
tion, but also because of specific biochemical reactions (Connor 
and Menzies, 1996) that generate free radicals. During periods of 
elevated ROS, such as in oxidative stress, DNA and other cellular 
constituents such as RNA, proteins and lipids are susceptible to 
oxidation. Interestingly, numerous studies link MDD to elevated 
oxidative stress conditions, but the majority of this evidence 
arises from measurements of oxidative stress-related indices in 
blood components. For example, elevated levels of lipid peroxi-
dation products (Bilici et al., 2001; Selley, 2004; Sarandol et al., 
2006; Dimopoulos et al., 2008; Yager et al., 2010), DNA oxidation 
(Forlenza and Miller, 2006), and shortened telomeres (Simon 
et al., 2006; Kinser and Lyon, 2013; Verhoeven et al., 2013), have 
been measured in blood components of MDD patients. In addi-
tion, reduced plasma concentrations of free radical scavengers 
(Maes et al., 2000, 2011; Owen et al., 2005) have also been found 
in MDD. Fewer studies have examined indices of oxidative pro-
cesses in the brains of MDD subjects. Che et al. (2010) demon-
strated elevated levels of oxidized RNA in hippocampal neurons 
using postmortem tissue from MDD, bipolar disorder and schiz-
ophrenia brain donors. DNA oxidation was also examined in 
hippocampal neurons, but showed only a trend for an elevation 
in MDD donors. Kim HK et al. (2014) reported elevated oxidation 
and nitration of proteins in prefrontal cortices from bipolar dis-
order and schizophrenia brain donors, but no significant effects 
were observed in prefrontal cortex of MDD donors. To date, no 
study has investigated the potential role of oxidative damage to 
white matter in MDD, other than the work by our lab (Szebeni 
et al., 2014). Hence, the present study is the first of two studies 
to implicate oxidative damage to white matter in the pathology 
of MDD.
Myelinating oligodendrocytes are the predominant cell type 
in brain white matter. Among cell types in the brain, oligo-
dendrocytes are known to be uniquely vulnerable to oxidative 
stress, with extensive lipid membranes being a primary target 
of free radicals (Kim and Kim, 1991; Thorburne and Juurlink, 
1996), increased oxidative load due to lipid production for mye-
lination, relatively low glutathione reductase enzyme activ-
ity (Juurlink et  al., 1998), and high levels of iron (Connor and 
Menzies, 1996; Thorburne and Juurlink, 1996), a pro-oxidant. 
Previously, we found the first preliminary evidence of oxidative 
damage to white matter oligodendrocytes in the brain in MDD 
(Szebeni et  al., 2014). In this previous study, oligodendrocytes, 
but not astrocytes, laser captured from two white matter regions 
(uncinate fasciculus and BA10) demonstrated shorter relative 
telomere lengths in MDD brain donors as compared to psychi-
atrically normal control subjects. These initial findings led us to 
speculate that elevated DNA oxidation may be responsible for 
the shorter telomeres in oligodendrocytes from MDD donors. 
The present findings demonstrating elevated levels of 8OHdG 
in white matter from BA10 of MDD brain donors, support the 
hypothesis that shorter telomeres in white matter oligodendro-
cytes in MDD is a result of elevated DNA oxidation in MDD.
Elevated DNA oxidation was observed in prefrontal cortical 
white matter but not gray matter in rats exposed to repeated psy-
chological stress. Differential sensitivity of various brain regions 
to oxidative damage is known. For example, the hippocampal 
CA1 region of the brain is more vulnerable to oxidative stress 
than the hippocampal CA3 region or the cerebral cortex (Wang 
et al., 2009). The apparent lack of elevated DNA oxidation in the 
gray matter from stressed rats may be a result of the fact that 
the fraction of all cells that are oligodendrocytes in white mat-
ter is much greater than that fraction in gray matter. In humans, 
glia considerably outnumber neurons (approximately 15 to 1) in 
cortical white matter, whereas numbers of glia and neurons are 
more similar in cortical gray matter (approximately 1.4 glia to 
1 neuron) (Azevedo et al., 2009). Considering that oligodendro-
cytes are uniquely susceptible to oxidiatve stress, DNA oxida-
tion may be occurring in gray matter oligodendrocytes but it is 
not detectable because of a signal dilution by other unaffected 
glia and neurons.
Since oligodendrocytes are normally susceptible to oxida-
tive damage, elevated levels of DNA oxidation observed in oli-
godendrocytes in MDD relative to normal controls suggest that 
susceptibility to oxidative damage is worsened in MDD. Gene 
expressions of four antioxidant genes were observed to be low 
in MDD oligodendrocytes as compared to oligodendrocytes 
from normal control subjects (Szebeni et  al., 2014). Some of 
these genes are downregulated by glucocorticoids (Pereira et al., 
1995; McIntosh et al., 1998; Schmidt et al., 2005), suggesting that 
elevated stress hormones in MDD may contribute to enhanced 
susceptibility of oligodendrocytes to oxidative damage in MDD. 
Low levels of circulating antioxidants in MDD could conceiv-
ably also contribute to enhanced oxidative damage to normally 
susceptible oligodendrocytes. Low blood levels of antioxidants, 
e.g. vitamin E, glutathione, coenzyme Q, and ascorbic acid, have 
been reported in depressed patients (Maes et al., 2011). However, 
the impact of varying diets on levels of circulating antioxidants 
is difficult to assess in studies involving human postmortem 
brain tissues.
The observations of elevated gene expression of the BER 
enzymes, PARP1 and OGG1, in white matter oligodendrocytes 
provide additional evidence of enhanced DNA oxidation in 
these cells in MDD. Gene expression of both of these enzymes 
is induced by conditions of oxidative stress (Liu et al., 2000; Lan 
et al., 2003; Adaikalakoteswari et al., 2007) presumably as a com-
pensatory mechanism to enhance BER. The correlation of PARP1 
and OGG1 expression levels in both glial cells from all donors in 
the present study is consistent with a coordinated response of 
these cells to DNA oxidation. This correlation of PARP1 and OGG1 
expression levels has also been observed in dysplastic cells 
from cancer patients (Dziaman et al., 2014). Extensive activity of 
PARP1 depletes nicotinamide adenine dinucleotide (NAD+) and 
ATP that are essential to generate PAR polymers and cells can die 
from energy loss (Berger, 1985; Ha and Snyder, 1999; Fouquerel 
and Sobol, 2014). In a mature myelinating oligodendrocyte, 
NAD+ and ATP are critically important to myelin lipid synthesis 
for the myelin sheath that encloses segments of neuronal axons. 
Szebeni et al. | 371
Hence, it is conceivable that elevated PARP activity, in response 
to oxidative damage to DNA in oligodendrocytes could deplete 
cellular energy supplies in MDD and interrupt important func-
tions of these cells, particularly those that are highly energy 
dependent and critical to normal neurotransmission.
While PARP1 and OGG1 are major components of the BER 
apparatus, both enzymes are also involved in other cellular pro-
cesses. PARP is a highly complex protein that engages in several 
cellular functions, including regulation of transcription through 
modifying chromatin structure, angiogenesis, mitochondrial 
energy metabolism and cell division (Martínez-Bosch et al., 2016). 
Of particular relevance to the study of MDD are PARP1 interac-
tions with many transcription factors involved in regulation of 
inflammatory gene expression such as nuclear factor-kappa B 
(NF-KB) (Oliver et  al., 1999). In fact, poly(ADP-ribosyl)ation by 
PARP1 is a necessary step in the activation of NF-KB induced 
by DNA damage (Stilmann et  al., 2009). Recent evidence also 
suggests that PAR chains, once cleaved from proteins poly(ADP-
ribosy)lated by PARP activity, act as damage associated molecu-
lar patterns that drive inflammation (Krukenberg et  al., 2015). 
Likewise, recent evidence demonstrates that mice deficient 
in OGG1 have impaired immune responses, and that repair of 
oxidized DNA also results in an OGG1-dependent activation of 
NF-KB (Aguilera-Aguirre et al., 2014). Hence, these studies dem-
onstrate that oxidation of oligodendrocyte DNA could be an ini-
tial step in the activation of inflammatory cascades that could 
contribute to further damaging effects on these and surrounding 
cells, including further generation of ROS by activation of micro-
glia. Interestingly, elevated numbers of activated microglia in 
postmortem brain white matter from depressed suicide victims 
have been reported (Torres-Platas et al., 2014). Collectively, these 
findings contribute to growing evidence of a role of inflamma-
tion in MDD (Swardfager et al., 2016), and studies demonstrating 
that anti-inflammatory compounds have therapeutic utility in 
the treatment of depressive disorders (Fond et al., 2014).
Only one previous study has reported a relationship between 
DNA oxidation and anhedonia in rats. Sigwalt and cowork-
ers (2011) exposed rats to dexamethasone daily for 21 days to 
induce anhedonia as measured by the sucrose preference test. 
Dexamethasone-treated animals demonstrated significantly 
elevated DNA oxidation in the CA1 of the hippocampus, an area 
of the brain containing neurons known to particularly suscep-
tible to oxidative damage (Wilde et al., 1997; Wang et al., 2005). 
In the present study, repeated exposure to social defeat and 
chronic unpredictable stress resulted in an elevation of DNA 
oxidation of white matter, as well as anhedonia. While oxida-
tive damage to white matter cells alone may be insufficient to 
produce anhedonia, other susceptible brains cells such as the 
hippocampus CA1 neurons may be similarly negatively affected 
by psychological stress-induced oxidative damage. Regardless 
of the specific cellular cause of anhedonia, elevated white mat-
ter DNA oxidation in anhedonic rats are consistent with white 
matter findings in human MDD donors, reducing the likelihood 
that DNA oxidation in human MDD donors is secondary to other 
confounding variables (smoking, drug exposures, environmen-
tal toxin exposures, dietary variables) associated with human 
postmortem tissue studies.
There are several limitations of the present study that must 
be taken into consideration with regard to conclusions drawn 
from the data. The sample sizes of the present study are rela-
tively small and findings need to be replicated in a larger group 
of human brain donors. While oxidative stress can regulate the 
expression of PARP1, the PARP1 enzyme activity is acutely regu-
lated by binding to damaged DNA that increases its activity by 
>500-fold (Martínez-Bosch et al., 2016). Hence, while elevated 
PARP1 and OGG1 expressions were observed in MDD, PARP1 
or OGG1 enzymatic activities have not been measured. PARP 
activity would presumably be a difficult undertaking given 
detrimental effects of the postmortem interval on enzyme 
activities. Additionally, whether elevated gene expressions are 
accompanied by increases in protein is not known. It is noted 
that PARylation is rapidly degraded by poly(ADP-ribose) glyco-
hydrolase (PARG) resulting in rapid downregulation of PARP1 
activity (Davidovic et al., 2001). Given that, changes in PARP1 
activity associated with disease may be difficult to observe 
in postmortem human tissues or in blood cells from living 
patients.
Numerous psychiatric and neurological disorders are asso-
ciated with elevated white matter hyper-intensities and other 
indicators of white matter pathology. The cellular bases of these 
in vivo findings have not yet been clarified. Glia are abundant in 
white matter and abnormalities in glia morphology, cell num-
ber and gene and protein expression have been described in the 
postmortem human brain from MDD brain donors. The present 
findings provide additional evidence of white matter pathology 
in MDD, and draw attention to potential molecular mechanisms 
that may be involved in the etiology of white matter pathol-
ogy. Elevated BER activity in oligodendrocytes, secondary to 
oxidative damage to these susceptible cells, may drive other 
deleterious energy-depleting and/or inflammatory processes 
that further contribute to oligodendrocyte dysfunction. Given 
the critical role of oligodendrocytes in facilitating neurotrans-
mission, disruption of oligodendrocyte function could play a 
critical role in the development of depression. Searching for 
compounds that could inhibit pathways activated by elevated 
BER activity has the potential to unearth novel antidepressant 
mechanisms.
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